Reduction of cardiovascular risk in patients with metabolic syndrome in a community health center after a pharmaceutical care program of pharmacotherapy follow-up. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 48, n. 3, p. 435–446, 2012. DOI: 10.1590/S1984-82502012000300010. Disponível em: https://www.journals.usp.br/bjps/article/view/47857.. Acesso em: 9 jun. 2024.